biotech
Assessment of Big BioPharma Merger Under Way in US, EU, and UK
Would the combined company use improper tactics to foreclose competition? Review of the $43 billion biopharmaceutical merger of drug giant Pfizer Inc. and biopharmaceutical company…
Sanofi Announces $2.9 Billion Acquisition of BioPharma Diabetes Drug Maker
Paris-based Sanofi S.A. announced a definitive agreement to pay $2.9 billion for diabetes drug manufacturer Provention Bio, Inc., a U.S.-based, biopharmaceutical company focused on intercepting…